Your browser doesn't support javascript.
loading
Green Liquid Chromatography Method for the Determination of Related Substances Present in Olopatadine HCl Nasal Spray Formulation, Robustness by Design Expert.
Kowtharapu, Leela Prasad; Katari, Naresh Kumar; Sandoval, Christian A; Muchakayala, Siva Krishna; Rekulapally, Vijay Kumar.
Afiliación
  • Kowtharapu LP; Shenzhen DEC Pharmaceutical Co., Ltd, Analytical Development Department, Shenzhen, China.
  • Katari NK; GITAM Deemed to be University, Department of Chemistry, School of Science, Hyderabad, Telangana 502329, India.
  • Sandoval CA; GITAM Deemed to be University, Department of Chemistry, School of Science, Hyderabad, Telangana 502329, India.
  • Muchakayala SK; Shenzhen DEC Pharmaceutical Co., Ltd, Analytical Development Department, Shenzhen, China.
  • Rekulapally VK; Douglas Pharma US, Inc., Analytical Research and Development, 1035 Louis Drive, Warminster, PA 18974, USA.
J AOAC Int ; 105(5): 1247-1257, 2022 Sep 06.
Article en En | MEDLINE | ID: mdl-35686891
ABSTRACT

BACKGROUND:

Dual therapeutic nature drug mast cell stabilizer and histamine receptor antagonist olopatadine hydrochloride (OPT) nasal spray does not have an official monograph, and no literature is available. Eye drops formulation had the official monograph for impurities, but the determination was done in two methods.

OBJECTIVE:

A simple and effective green liquid chromatography method to develop and validate for the related substances of OPT nasal spray formulation.

METHOD:

A 25 min gradient method was employed to separate impurities and OPT with a 1.0 mL/min flow rate using a Boston green C8 (150 mm × 4.6 mm, 5 µm) HPLC column. The set wavelength and column oven temperatures were 299 nm and 30°C, respectively. pH 3.5 phosphate buffer-acetonitrile in the ratio of (7030, v/v) as mobile phase A and (5050, v/v) ratio as mobile phase B. A Quality by Design (QbD) based Design of Experiments (DoE) was employed to evaluate the robustness characteristics of the analytical method validation.

RESULTS:

The obtained RSD from the precision and intermediate precision was 0.4 to 4.1%. The % recovery of the impurities from LOQ to 150% of specification level was 87.5 to 110.3%. The linear regression curves for the impurities with a correlation coefficient of >0.999 indicate that all peak responses are linear with the concentration. The sample and standard solutions were stable for 24 h at benchtop and refrigerator conditions.

CONCLUSIONS:

All the critical peaks were well separated from the forced degradation studies' diluent, placebo, and generated degradation peaks. The method validation data and QbD based robustness study results indicate that the developed impurities method fits the routine quality control laboratory use. National Environmental Index (NMEI), Green Analytical Procedure Index (GAPI), Analytical Eco-scale and Analytical Greenness (AGREE) tools expressed the method's greenness. HIGHLIGHTS The proposed method is QbD utilized and green chemistry assessed impurities determination method for OPT in nasal spray formulation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Contaminación de Medicamentos / Rociadores Nasales Tipo de estudio: Clinical_trials Idioma: En Revista: J AOAC Int Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Contaminación de Medicamentos / Rociadores Nasales Tipo de estudio: Clinical_trials Idioma: En Revista: J AOAC Int Año: 2022 Tipo del documento: Article País de afiliación: China